2024 Opportunities, Heart-y Gains, Vice City Real Estate 12/28/23

With stocks at or near record highs, our market guest says the gains can continue and is highlighting the parts of the market that he sees as undervalued. Plus, a blowout finish for biotech stocks to end the year – we’ll speak to one CEO whose company is coming off its best day ever thanks to the success of a heart disease drug. And our latest check on commercial real estate takes us down to Miami.